Computational modelling of valvular heart disease: haemodynamic insights and clinical implications

被引:0
|
作者
Seman, Michael [1 ,2 ,3 ]
Stephens, Andrew F. [2 ,4 ]
Kaye, David M. [2 ,3 ,5 ,6 ]
Gregory, Shaun D. [2 ,4 ]
Stub, Dion [1 ,2 ,3 ,5 ]
机构
[1] Monash Univ, Sch Publ Hlth & Preventat Med, Melbourne, Vic, Australia
[2] Monash Univ, Dept Mech & Aerosp Engn, Cardioresp Engn & Technol Lab, Melbourne, Vic, Australia
[3] Alfred Hlth, Dept Cardiol, Melbourne, Vic, Australia
[4] Queensland Univ Technol, Ctr Biomed Technol, Brisbane, Qld, Australia
[5] Baker Heart & Diabet Inst, Cardiol & Therapeut Div, Melbourne, Vic, Australia
[6] Monash Univ, Sch Med, Melbourne, Vic, Australia
来源
FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY | 2024年 / 12卷
基金
澳大利亚国家健康与医学研究理事会; 英国医学研究理事会;
关键词
cardiovascular model; mathematical model; lumped parameter; aortic stenosis; mitral regurgitation; CARDIOVASCULAR-SYSTEM; AORTIC-STENOSIS; TRICUSPID REGURGITATION; PARAMETER MODEL; VALVE STENOSIS; ASSIST DEVICE; SIMULATION; RECOMMENDATIONS; DYNAMICS;
D O I
10.3389/fbioe.2024.1462542
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
An aging population and an increasing incidence of cardiovascular risk factors form the basis for a global rising prevalence of valvular heart disease (VHD). Research to further our understanding of the pathophysiology of VHD is often confined to the clinical setting. However, in recent years, sophisticated computational models of the cardiovascular system have been increasingly used to investigate a variety of VHD states. Computational modelling provides new opportunities to gain insights into pathophysiological processes that may otherwise be difficult, or even impossible, to attain in human or animal studies. Simulations of co-existing cardiac pathologies, such as heart failure, atrial fibrillation, and mixed valvular disease, have unveiled new insights that can inform clinical research and practice. More recently, advancements have been made in using models for making patient-specific diagnostic predictions. This review showcases valuable insights gained from computational studies on VHD and their clinical implications.
引用
收藏
页数:16
相关论文
共 50 条
  • [31] Serelaxin: insights into its haemodynamic, biochemical, and clinical effects in acute heart failure
    Hernandez, Adrian V.
    EUROPEAN HEART JOURNAL, 2014, 35 (07) : 410 - 412
  • [32] Valvular Heart Disease
    Kisling, Adam
    Gallagher, Robert
    PRIMARY CARE, 2024, 51 (01): : 95 - 109
  • [33] Valvular heart disease
    Lipton, MJ
    Coulden, R
    RADIOLOGIC CLINICS OF NORTH AMERICA, 1999, 37 (02) : 319 - +
  • [34] Valvular heart disease
    Baldwin, J
    CURRENT OPINION IN CARDIOLOGY, 1998, 13 (02) : 79 - 79
  • [35] Valvular heart disease
    Hara, JH
    PRIMARY CARE, 2000, 27 (03): : 725 - +
  • [36] Valvular heart disease
    Baldwin, JC
    CURRENT OPINION IN CARDIOLOGY, 2000, 15 (02) : 73 - 73
  • [37] Valvular heart disease
    Bonow, RO
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1999, 34 (02) : 315 - 317
  • [38] Valvular heart disease
    Baldwin, JC
    CURRENT OPINION IN CARDIOLOGY, 2004, 19 (02) : 116 - 116
  • [39] Valvular heart disease
    S. Globits
    Der Radiologe, 1997, 37 : 341 - 350
  • [40] Valvular heart disease
    Homler, H
    NEW ENGLAND JOURNAL OF MEDICINE, 1997, 337 (20): : 1474 - 1475